Bellevue Group’s Sanofi SNY Stock Holding History

Bellevue Group’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,851	Closed	-$284K	–	190
2025 Q4	$284K	Sell	5,851 -3,009	-34%	-$149K	0.01%	148
2025 Q3	$418K	Buy	+8,860	New	+$428K	0.01%	117
2025 Q2	–	Sell	-16,000	Closed	-$887K	–	151
2025 Q1	$887K	Buy	+16,000	New	+$866K	0.02%	108
2024 Q4	–	Sell	-15,109	Closed	-$871K	–	174
2024 Q3	$871K	Buy	+15,109	New	+$816K	0.01%	121
2022 Q3	–	Sell	-42,300	Closed	-$2.12M	–	185
2022 Q2	$2.12M	Sell	42,300 -1,300	-3%	-$69K	0.03%	127
2022 Q1	$2.24M	Buy	+43,600	New	+$2.25M	0.03%	131
2021 Q4	–	Sell	-67,000	Closed	-$3.23M	–	219
2021 Q3	$3.23M	Sell	67,000 -1,000	-1%	-$50.8K	0.03%	141
2021 Q2	$3.58M	Buy	+68,000	New	+$3.55M	0.04%	135
2020 Q4	–	Sell	-57,000	Closed	-$2.86M	–	227
2020 Q3	$2.86M	Hold	57,000	–	–	0.04%	137
2020 Q2	$2.91M	Buy	+57,000	New	+$2.77M	0.04%	129

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Bellevue Group's SNY Position: Q1 2026 in Review

Bellevue Group sold out of Sanofi (SNY) in Q1 2026, closing a stake of 5,851 shares — an estimated $284K sold.

Bellevue Group first reported a position in SNY in Q2 2020 and held it in 10 quarters. The position peaked at $3.58M in Q2 2021. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

Bellevue Group reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
Bellevue Group sold 5,851 Sanofi shares in Q1 2026, an estimated $284K.
Bellevue Group first reported a position in Sanofi in Q2 2020 and held it in 10 quarters.
Bellevue Group's Sanofi position peaked at $3.58M in Q2 2021.
737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Bellevue Group's 13F filing for Q1 2026, filed 15 May 2026.